Vivos Therapeutics
VVOS
VVOS
27 hedge funds and large institutions have $630K invested in Vivos Therapeutics in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
54% less capital invested
Capital invested by funds: $1.38M → $630K (-$749K)
Holders
27
Holding in Top 10
–
Calls
$6K
Puts
$1K
Top Buyers
| 1 | +$5.96K | |
| 2 | +$4.91K | |
| 3 | +$3.65K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.51K |
| 5 |
Renaissance Technologies
New York
|
+$1.16K |
Top Sellers
| 1 | -$236K | |
| 2 | -$51K | |
| 3 | -$27K | |
| 4 |
SWM
SeaCrest Wealth Management
Purchase,
New York
|
-$26K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$6.82K |